At a glance
- Originator Uniroyal Chemical
- Developer CONRAD
- Class Amides; Antiretrovirals; Furans; Small molecules
- Mechanism of Action Non-nucleoside reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in HIV-infections(Prevention) in Thailand (Vaginal, Gel)
- 04 Nov 2017 No recent reports of development identified for phase-I development in HIV-infections(Prevention) in USA (Vaginal, Gel)
- 11 Feb 2009 Final pharmacodynamics and adverse events data from a phase I trial in HIV infections presented at the 16th Conference on Retroviruses and Opportunistic Infections (CROI-2009),